Literature DB >> 8323328

Sepsis and intravascular thrombosis.

R S Heyderman1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8323328      PMCID： PMC1029328          DOI： 10.1136/adc.68.5.621

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  23 in total

Review 1.  Modulators of coagulation. A critical appraisal of their role in sepsis.

Authors:  R C Bone
Journal:  Arch Intern Med       Date:  1992-07

2.  Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass.

Authors:  G D Angelini; G J Cooper; M Lamarra; A J Bryan
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

3.  Severity of meningococcal disease: assessment by factors and scores and implications for patient management.

Authors:  T W Gedde-Dahl; P Bjark; E A Høiby; J H Høst; J N Bruun
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

4.  Fulminating meningococcic infections and the so-called Waterhouse-Friderichsen syndrome.

Authors:  J H FERGUSON; O D CHAPMAN
Journal:  Am J Pathol       Date:  1948-07       Impact factor: 4.307

5.  Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease.

Authors:  P Brandtzaeg; G B Joø; B Brusletto; P Kierulf
Journal:  Thromb Res       Date:  1990-01-15       Impact factor: 3.944

Review 6.  Disseminated intravascular coagulation (DIC): an approach.

Authors:  R W Colman; S J Robboy; J D Minna
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

7.  Meningococcal purpura: report of 19 patients treated with heparin.

Authors:  P Gérard; M Moriau; A Bachy; P Malvaux; R De Meyer
Journal:  J Pediatr       Date:  1973-05       Impact factor: 4.406

8.  Changes in the blood coagulation system associated with septicemia.

Authors:  J J Corrigan; W L Ray; N May
Journal:  N Engl J Med       Date:  1968-10-17       Impact factor: 91.245

9.  Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil-derived agonists.

Authors:  P Renesto; C Kadiri; M Chignard
Journal:  Br J Haematol       Date:  1992-02       Impact factor: 6.998

10.  Deficiency of prostacyclin production in meningococcal shock.

Authors:  R S Heyderman; N J Klein; G I Shennan; M Levin
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791
View more
  6 in total

Review 1.  Recognition, treatment and complications of meningococcal disease.

Authors:  F A Riordan; A P Thomson
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

2.  Prediction of neonatal sepsis by thromboelastography.

Authors:  H W Grant; G P Hadley
Journal:  Pediatr Surg Int       Date:  1997-04       Impact factor: 1.827

3.  Modulation of the endothelial procoagulant response to lipopolysaccharide and tumour necrosis factor-alpha in-vitro: the effects of dexamethasone, pentoxifylline, iloprost and a polyclonal anti-human IL-1 alpha antibody.

Authors:  R S Heyderman; N J Klein; O A Daramola; M Levin
Journal:  Inflamm Res       Date:  1995-07       Impact factor: 4.575

Review 4.  COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.

Authors:  Che Mohd Nasril Che Mohd Nassir; Sabarisah Hashim; Kah Keng Wong; Sanihah Abdul Halim; Nur Suhaila Idris; Nanthini Jayabalan; Dazhi Guo; Muzaimi Mustapha
Journal:  Mol Neurobiol       Date:  2021-06-26       Impact factor: 5.590

5.  Identification of differentially expressed serum proteins in infectious purpura fulminans.

Authors:  Ting He; Jiong-yu Hu; Jian Han; Dong-xia Zhang; Xu-pin Jiang; Bing Chen; Yue-sheng Huang
Journal:  Dis Markers       Date:  2014-02-10       Impact factor: 3.434

Review 6.  Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models.

Authors:  Nonantzin Beristain-Covarrubias; Marisol Perez-Toledo; Mark R Thomas; Ian R Henderson; Steve P Watson; Adam F Cunningham
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.